NHS doctors in the UK strike over pay disputes, demanding 26% raises amid government offers of 3.5%. Contingency measures aim to maintain care, but strikes risk £300m in costs and service disruptions, marking the 15th such action since 2023.

Baxdrostat, a first-in-class aldosterone inhibitor, shows significant blood pressure reduction in resistant hypertension, with 9–10 mmHg drops in trials. Its global potential could help over half a billion people, including 10 million in the UK, as highlighted at ESC 2025 and published in NEJM.

Oregon health officials warn of measles outbreak risk in under-vaccinated areas, citing 13 confirmed cases and wastewater data showing broader circulation. National trends reveal 1,671 U.S. cases in 2026, linked to low vaccination rates and global spread, urging urgent public health action.

A study links monthly binge drinking to tripled liver scarring risk in MASLD patients, per *Clinical Gastroenterology and Hepatology*. Episodic heavy alcohol use—defined as four+ drinks monthly for women, five+ for men—correlates with advanced fibrosis, even in moderate drinkers. Researchers warn binge patterns exacerbate liver damage, urging targeted public health interventions amid rising MASLD and alcohol-related liver disease rates.

ACC/AHA 2026 guidelines prioritize early risk assessment at 30, dynamic risk models, biomarker testing, and personalized LDL targets to enhance cardiovascular disease prevention.

MIT researchers created an implantable device using encapsulated insulin-producing cells and an oxygen generator, offering a potential cure for type 1 diabetes by eliminating daily injections. The system, tested in mice, maintains cell viability and regulates blood sugar without immune rejection, marking a breakthrough in diabetes management.

Epia Neuro’s groundbreaking BCI merges skull implants and AI-driven gloves to restore hand function in stroke patients, offering a novel rehabilitation approach leveraging neuroplasticity. The minimally invasive design targets 60,000 U.S. stroke survivors annually, aiming to revolutionize neurorehabilitation through scalable, AI-enhanced therapy.

Portland Safeway confirmed measles exposure between March 26-29, urging visitors to seek medical advice. Declining vaccination rates in Oregon, now over 8% unvaccinated kindergartners, heighten outbreak risks, officials warn.

A groundbreaking antiviral pill, MDL-001, shows promise in treating colds, flu, norovirus, and COVID-19, developed via AI to target a common viral enzyme. Trials set for 2027 will assess its safety and efficacy.

A groundbreaking gene therapy using AAV restored hearing in OTOF mutation patients, with children showing near-complete recovery. Published in *Nature Medicine*, the trial marks a major step toward curing genetic deafness by targeting root causes, offering long-term solutions beyond cochlear implants.